Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Venous Disease: Features

Editor's Corner
Venous Duplex Is Essential in Confirming Venous Insufficiency
05/16/2018
Dr. Walker comments on the diagnosis of venous insufficiency and discusses the new device options available for the treatment of superficial venous insufficiency.
Dr. Walker comments on the diagnosis of venous insufficiency and discusses the new device options available for the treatment of superficial venous insufficiency.
Dr. Walker comments on the...
05/16/2018
Vascular Disease Management
Case Report
Large Popliteal Vein Aneurysm Case Report: A Challenging Surgical Treatment
04/06/2018
Popliteal venous aneurysms are a rare entity that at times can be fatal in the setting of pulmonary emboli. We report a case of a large popliteal venous aneurysm in a patient with a history of pulmonary embolism.
Popliteal venous aneurysms are a rare entity that at times can be fatal in the setting of pulmonary emboli. We report a case of a large popliteal venous aneurysm in a patient with a history of pulmonary embolism.
Popliteal venous aneurysms are a...
04/06/2018
Vascular Disease Management
Conference Coverage
The ATTRACT Trial: Understanding the Results
01/17/2018
The recent publication of the landmark ATTRACT trial has offered important data on the treatment of acute deep vein thrombosis (DVT). Anthony Comerota, MD, is one of the authors of the paper, and he joined us to explain the findings of the...
The recent publication of the landmark ATTRACT trial has offered important data on the treatment of acute deep vein thrombosis (DVT). Anthony Comerota, MD, is one of the authors of the paper, and he joined us to explain the findings of the...
The recent publication of the...
01/17/2018
Vascular Disease Management
Conference Coverage
State-of-the-Art Care for Venous Ulcers
01/03/2018
Treatment of venous ulcers is an important, yet often overlooked, part of comprehensive vascular care. In this Q&A, Raghu Kolluri, MD, updates clinicians on the patient burden, the challenges of working in a fragmented care structure, and on...
Treatment of venous ulcers is an important, yet often overlooked, part of comprehensive vascular care. In this Q&A, Raghu Kolluri, MD, updates clinicians on the patient burden, the challenges of working in a fragmented care structure, and on...
Treatment of venous ulcers is an...
01/03/2018
Vascular Disease Management
Original Research
Use of VASCADE Vascular Closure System for Venous Hemostasis
08/07/2017
The authors investigate whether vascular closure devices selected for characteristics optimal for venous closure can deliver a safe and effective way to achieve rapid hemostasis.
The authors investigate whether vascular closure devices selected for characteristics optimal for venous closure can deliver a safe and effective way to achieve rapid hemostasis.
The authors investigate whether...
08/07/2017
Vascular Disease Management
Case Report
Revascularization of Chronic Venous Occlusion in the Setting of Post-Thrombotic Syndrome
03/16/2017
Post-thrombotic syndrome is a complication that may follow deep vein thrombosis, and is associated with significant morbidity. There is growing interest in endovascular techniques to treat this complication. We present a related case.
Post-thrombotic syndrome is a complication that may follow deep vein thrombosis, and is associated with significant morbidity. There is growing interest in endovascular techniques to treat this complication. We present a related case.
Post-thrombotic syndrome is a...
03/16/2017
Vascular Disease Management
Case Report
Popliteal Vein Aneurysms
01/26/2015
The authors report a case of a large popliteal aneurysm that resulted in a pulmonary embolus. The diagnosis, and more importantly surgical management, of primary venous aneurysms remain uncertain. This case highlights the diagnosis and...
The authors report a case of a large popliteal aneurysm that resulted in a pulmonary embolus. The diagnosis, and more importantly surgical management, of primary venous aneurysms remain uncertain. This case highlights the diagnosis and...
The authors report a case of a...
01/26/2015
Vascular Disease Management
Interview
Injectable Varithena Foam Therapy for Varicose Veins
08/24/2014
The injectable foam Varithena was recently approved by the FDA for treatment of varicose veins. Vascular Disease Management speaks about the therapy with Dr. Marlin Schul, who participated in a trial that led to its approval.
The injectable foam Varithena was recently approved by the FDA for treatment of varicose veins. Vascular Disease Management speaks about the therapy with Dr. Marlin Schul, who participated in a trial that led to its approval.
The injectable foam Varithena...
08/24/2014
Vascular Disease Management
Review
Vena Cava Filters: Too Often, Too Many, or Just Right?
04/30/2014
The authors discuss the available types of inferior vena cava filters, their main indications, evidence behind their use, and patterns of their utilization.
The authors discuss the available types of inferior vena cava filters, their main indications, evidence behind their use, and patterns of their utilization.
The authors discuss the...
04/30/2014
Vascular Disease Management
Interview
Current Therapy for Chronic DVT: An Interview With Mark J. Garcia, MD
08/23/2013
The current standard of care for deep-vein thrombosis could soon be moving away from anticoagulant and compression stocking to endovascular therapy.
The current standard of care for deep-vein thrombosis could soon be moving away from anticoagulant and compression stocking to endovascular therapy.
The current standard of care for...
08/23/2013
Vascular Disease Management

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

First Aid guidelines
AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies
11/14/2024
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major...
11/14/2024
Cath Lab Digest
Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Late-Breaking Trials
First Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Image-Guided Therapy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease
11/04/2024
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
Peripheral Arterial Disease
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
11/04/2024
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November...
11/04/2024
Vascular Disease Management
Patient Awareness
Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases
10/31/2024
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in...
10/31/2024
Vascular Disease Management
DCB
SIRONA Trial @TCT – First Head-to-Head Comparison of Sirolimus Versus Paclitaxel DCBs in the Treatment of PAD: Sirolimus-Coated Balloons Yield Similar Results to Paclitaxel-Coated Balloons in the Femoropopliteal Artery
10/30/2024
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective,...
10/30/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement